drugset / Trial / NCT07476963
Evaluation of the Food Effecton the Pharmacokinetics of FWD1802 in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
A Phase I, Single-Center, Open-Label, Randomized, Single-Dose, Three-Period Crossover Study to Evaluate the Effect of High-Fat and Low-Fat Meals on the Pharmacokinetics of FWD1802 in Chinese Healthy Subjects. The primary objectives are to address the following questions: To evaluate the impact of high-fat and low-fat meals on the pharmacokinetic (PK) characteristics of a single oral dose of FWD1802 in healthy Chinese Subjects.
Timeline
- Start
- 2026-03-15
- Primary completion
- 2026-07-06
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FWD1802 | Unknown | 150 mg | Oral |
Indications
No indication recorded.